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Abstract
Six new N-substituted di- and tributyltin 2-aminoethanethiolates (cysteaminates) have been prepared
and characterised by H, 3C and 9Sn NMR spectroscopy. All these compounds exhibit a good in vitro
antifungal effect against selected types of human pathogenic fungi (Candida albicans, Candida krusei,
Candida tropicalis, Candida glabrata, Trichosporon beigelii, Aspergillus fumigatus, Absidia corymbifera,
Trichophyton rnentagrophytes) and their activity is comparable with that of some antifungal drugs commonly
used in the clinical use like ketoconazole. The structure-activity relationships in these compounds are
discussed.
Introduction
The organotin 2-aminoethanethiolates (cysteaminates) have been studied previously for their potential
polydonor abilities. However, biological properties, especially antifungal effects, of these compounds
containing biologically interesting group SCH_,CHzN are almost unknown. It has been discovered recently
that compounds of this type exhibit a relatively high in vitro antitumour activity-. Unfortunately, low
solubility of these derivatives in water blocks further research in this context3. On the other hand, the
lipophilic character of these derivatives seems to be no hamper for their antifungal effect. Thus, the set of
new butyltin derivatives containing N-substituted group SCH2CH2N has been prepared and their in vitro
activity against some medically important yeasts (Candida albicans, Candida krusei, Candida tropicalis,
Candida glabrata, Trichosporon beigelii) and molds (Aspergilhts fitmigatus, A bsidia cotymbifera,
Trichophyton mentagrophytes) has been investigated.
Results and discussion
The six new N-substituted organotin 2-aminoethanethiolates have been prepared: tributyltin-(2)-(l-
piperidyl)ethylthiolate (1), tributyltin-2-(4-morfolinyl)ethylthiolate (2), tributyltin-2-(4-methylpiperazinyl)
ethylthiolate (3) and dibutyltin-bis[2-(l-piperidyl)ethylthiolate] (4), dibutyltinbis[2-(4-morfolinyl)
ethylthiolate] (5), dibutyltinbis[2-(4-methylpiperazinyl)ethyl-thiolate] (6). The general formula is given in
Scheme 1.
1 n=3;X=-CH2-
2 n =3; X=-O-
3 n=3;X=-NCH3
4 n 2; X =-CH2-
5 n=2;X=-O
6 n 2; X -NCH.
Scheme
The studied compounds have been prepared by the reaction of tri- or dibutyltin chloride with
corresponding N-substituted 2-aminoethanethiole in benzene solution in presence of natrium methoxide as a
base. The preparations were carried out under anaerobic conditions. All prepared organotin compounds are
colourless oils stable on air.
In the case of tributyltin derivatives (1-3) the values of (9Sn) and J(9Sn,3C) are about 80 ppm
and 330 Hz, respectively(s. Tab.IV.); the C-Sn-C angles, estimated4’5 from these values of coupling constants
are 108. These values indicate the presence of tetrahedrally bonded tin atom in the molecule, without any
significant interaction between tin and nitrogen atom4". The values of(9Sn) do not show any concentration
dependence and thus intermolecular association seems to be excluded. This conclusion is in agreement with
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the results of previous study of Bu3SnSCHzCHzNEt2 . For dibutyltin compounds (4-6) the values of
(l9Sn) and IJ(II9Sn,13C) are about 130 ppm and 378 Hz, respectively (s.Tab.IV.), similar to these data for
BuzSn(SCH,CHzNEtz)z , therefore, we suppose analogous structural features in these compounds (four-
coordinated tin atoms with C-Sn-C angle being 113).
In vitro antifungal screening.
The results of in vitro antifungal susceptibility testing against eight strains of potentially pathogenic
fungi for humans are given in Table as a minimal inhibitory concentration (MIC, in lamol.l). For
comparison, the MIC values of tri-, dibutyltinchloride, Bu3SnCl (7), Bu2SnClz (8), acyclic tributyltin-2-(N,N-
dimethyl)aminoethanethiolate (9) and ketoconazole (KTZ) are given there, too.
The parent N-substituted thioles without organotin moiety did not show any activity against the fungal
strains tested. On the other hand, the studied organotin derivatives showed good antifungal effects which
were comparable with the in vitro activity of antifungal drugs like ketoconazole6. Tributyltin compounds
studied exhibit interesting antifungal effect towards some strains, against which ketoconazole is markedly
poorly active (e.g. AF, AC).
Tab. I. The MICs (gmol.l) of studied compounds determined by microdilution broth test
Fungal strain
(incubation time)
TM (72h)
(120h)
CA (24h)
(48h)
CT (24h)
(48h)
CK (24h)
(48h)
CG (24h)
(48h)
TB (24h)
(48h)
AF (24h)
(48h)
AC (24h)
(48h)
Compound
2 3 4 5 6 7 8 9 KTZ
0.031 0.061 0.061 0.49 3.91 0.49 0.195 1.95 0.122 0.98
0.061 0.061 0.122 1.95 3.91 0.98 0.195 1.95 0.24 1.95
0.008 0.008 0.015 0.98 0.98 7.81 0.049 7.81 0.015 0.12
0.49 0.49 0.24 3.91 1.95 15.63 0.049 15.63 0.24 0.12
0.98 0.49 0.49 7.81 7.81 31.25 0.39 31.25 0.49 1.95
0.98 1.95 0.98 15.63 7.81 62.50 0.78 62.50 0.98 3.91
0.49 0.49 0.24 3.91 0.195 15.63 0.195 15.63 0.24 3.91
0.98 0.49 0.49 3.91 0.39 15.63 0.195 15.63 0.49 3.91
0.98 0.49 0.49 7.81 7.81 31.25 0.39 31.25 0.49 0.24
1.95 1.95 0.98 15.63 15.63 62.50 0.78 62.50 1.98 0.98
1.95 1.95 1.95 7.81 7.81 15.63 0.78 31.25 0.98 0.12
3.91 7.81 3.91 15.63 15.63 31.25 1.563 62.50 1.95 0.24
0.122 1.95 0.24 3.91 1.95 15.63 0.098 7.81 0.24 15.63
1.95 1.95 0.98 7.81 7.81 15.63 0.39 15.63 0.98 15.63
0.49 0.49 0.24 3.91 0.195 15.63 0.098 15.63 0.24 31.25
0.98 0.49 0.49 7.81 0.195 31.25 0.098 15.63 0.49 31,25
TM: Trichophyton mentagrophytes 445, CA: Candida albicans ATCC 44859, CT: Candida tropicalis 156,
CK: Candida krusei E28, CG: Candida glabrata 20/I, TB: Trichosporon beigelii 1188, AF: Aspergillus
fumigatus 231, AC: Absidia corymbifera 272.
The data given in Table reveal higher antifungal effects of the tributyltin compounds 1-3 than that of
the dibutyltin analogues 4-6. These results correspond with the dependence of antifungal and antibacterial
activity of organotin compounds on the degree of tin atom alkylation in sequence RSnX3 < R2SnX2 < R4Sn
<< R3SnX. The organotin(IV) compounds with Sn-S bonding usually exhibit a considerable antifungal
activity8’9. The studied N-substituted butyltin 2-aminoethanthiolates exhibit different act!vity in comparison
with butyltin chlorides 7 and 8. Thus, dibutylstannyl derivatives 4 and 5 are more active than
dibutylstannyldichloride against seven of the eight fungal strains applied (except the mold TM). On the
contrary, the tributylstannyl derivatives 1-3 are less active than tributylstanny|chloride against six of the eight
fungal strains applied. The derivatives 1-3 are more active than tributylstannylchloride only against the mold
TM and the yeast CA (for one day incubation). These effects could be explained by different affinities of the
studied compounds to water. An important role in the antifungal activity plays here the equilibrium between
the lipophilic and hydrophilic character of the compounds during the transport through cell membranes.
The antifungal effect probably does not depend significantly on the structural changes of thiolate
substituent. From the comparison with Bu3SnSCH2CHzN(CH3)_ (9) it seems to be obvious, that the presence
of heterocyclic arrangement itself is not important for the antifungal effect of this type of compounds. The S-
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bonded substituent probably facilitates the transport through the cell membrane only, as it was already shown
by van der Kerk and Luijten l. In the case of butyltin compounds, in which the substituent exhibits a
biological effect as well, the synergic effect of substituent and butyltin group was observed lz.
Experimental
Syntheses
Starting amines were commercially available and were dried by distillation with CaH. Thiirane was
prepared from ethylene carbonate and KSCN 13. Benzene was dried by refluxing with sodium under argon
atmosphere and distilled before use. The preparations of sulfanylethylamines and butyltin derivatives were
carried out under Ar atmosphere using standard Schlenk technique.
N-(2-sulfanylethyl)-N’-methylpiperazine (X=-NCH3): N-methylpiperazine, (4 g; 40 mmol) was
dissolved in benzene (25 ml), than thiirane (2.4g; 40 mmol) dissolved in benzene (5 ml) was added in three
portions in the intervals of 30 minutes at 60 C. Then the mixture was stirred for 3 hours at 60C and refluxed
for 2 hours. The benzene was evaporated off under reduced pressure. Vacuum distillation (113-114 C/1 kPa)
of the residue afforded 4.4 g of colourless liquid (yield 68%).
The syntheses of other two 2-sulfanylethylamines were carried out using the same procedure with the
following results:
N-(2-sulfanylethyl)morpholine (X -0-): b.p. 92-92,5 C/l,1 kPa (yield 77 %).
N-(2-sulfanylethyl)piperidine (X -CH2-): b.p. 69-70 C/0,6 kPa (yield 64 %).
Synthesis of tributyltin-2-(4-methylpiperazinyl)ethylthiolate(3): N-(2-sulfanylethyl)-N’-
methylpiperazine (1 g; 6.24 mmol) was dissolved in benzene (30 ml) and then the solution of CH3ONa (3.74
ml 1.67 M; 6.24 mmol) was added dropwise. A solution of Bu3SnCI (2.03 g; 6.24 mmol) in benzene (20 ml)
was added and the reaction mixture was stirred at room temperature for 2 hours. The precipitate of NaCI was
filtrated off and the solvent was evaporated under reduced pressure. Vacuum distillation (155-8 C/18 Pa) of
the residue afforded 1.91 g of a colourless liquid (yield 68 %).
The other butyltin compounds (1, 2, 4-6) were prepared using the analogous procedure.
Boiling points and the results of the elemental analysis of the studied compounds are given in Table II. The
parameters ofNMR spectra are given in Tables III and IV. The relevant marking of skeletal atoms is shown
in Scheme 2.
Tab. II. The basic physicochemical and analytical parameters of the compounds 1-6.
compound
Boil. point [C/Pa]
yield [%]
Element. analysis %
C (found/calc)
H (found/calc)
N (found/calc)
S (found/calc)
Sn (found/calc)
1 2 3 4 5 6
120-2/12 115-20/5 155-8/18 165-7/8 172-4/7 183-5/2
66 51 68 71 61 60
52.94/52.55 49.52/49.56 51.03/50.79 50.33/50.68 45.69/45.72 47.86/47.92
9.50/9.52 9.10/9.01 9.39/9.42 8.81/8.89 8.12/8.06 8.85/8.77
3.10/3.23 3.15/3.21 6.18/6.23 5.41/5.37 5.26/5.33 10.00/10.16
7.48/7.38 7.29/7.35 7.08/7.14 12.36/12.30 11.96/12.21 11.49/11.63
27.35/27.33 27.28/27.21 26.48/26.42 22.83/22.76 22.50/22.59 21.59/21.52
2 3 4 3 4 3 4 :2 :2 S/N SN/---N 5 "-S
’-
N 5 O
-CH2CH2CHzCH3
Scheme 2
NMR sp. ectra
H, 3C and !19Sn NMR spectra were acquired at 360.13, 90.56 and 134.28 MHz, respectively, on
Bruker AMX 360 NMR spectrometer, using a 5mm tuneable broad band probe at 300K in CDCI3 solutions.
Chemical shifts are given with respect to (CH)4Si [(IH) (HMDS) 0.05ppm; i(13C) (CDCI3) 77.00
119 119, 14 ppm] and (CH3)aSn [t( Sn) 0.0 ppm for E Sn) 37.2906174 MHz] "9 13 13 n 11 C resonances were assigned on the basis of the values of J( Sn, C) coupling constants and
standard 13C- APT techniques utilization in agreement with ref.l.
H resonances were assigned by means of expected spectral patterns, integral intensities and chemical
shifts of non-bonded substituents
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Tab. III. The chemical shifts of the IHNMR resonances [ppm] ofcompounds 1-6.
8(H)
8
2
3
4
5
1 2 3 4 5 6
1.22 1.13 1.12 1.32 1.34 1.34-1.64
1.58 1.56 1.56 1.32-1.50 1.62 1.34-1.64
1.32 1.32 1.32 1.32-1.50 1.41 1.34-1.64
0.89 0.89 0.89 0.82 0.88 0.91
2.48 2.52 2.52 2.45 2.54 2.5-2.6
2.65 2.65 2.63 2.70 2.78 2.78
2.40 2.46 2.30-2.58 2.33 2.47 2.5-2.6
1.56 3.70 2.30-2.58 1.52 3.69 2.5-2.6
1.42 2.27 1.36 2.33
Tab. IV. The chemical shifts of the 3C and 9Sn NMR resonances [ppm] and nj(l9Sn,3C)coupling
constants [Hz] (in Parentheses ofcompounds 1-6.
2 3 4 5 6
Sn
8
2
3
4
5
79.7 80.5 80.2 126.3 130.6 129.2
13.3(330.14) 13.3(330.57) 13.3(329.45) 17.9(378.70) 18.0(377.31) 18.2(-
28.4(21.50) 28.5(21.56) 28.5(20.81) 28.1(24.94) 28.0(24.98) 28.2(26.4)
26.9(61.04) 26.9(61.04) 26.9(61.04) 26.6(74.9) 26.5(72.48) 26.6(76.3)
13.4(- 13.5(- 13.5(- 13.3(- 13.4(- 13.5(-
23.2 22.99 23.1 23.1 23.7 23.8
63.7 63.0 62.7 62.9 62.4 61.9
54.4 53.5 52.9 54.3 53.4 45.7
25.7 66.7 54.8 25.6 66.6 57.5
24.1 45.9 24.0 54.7
In vitro antifungal testing.
The in vitro antifungal testing was carried out by the modified microdilution broth format of the M27-
A guidelines 6. Quality control strains (Candida albicans ATCC 90028, C. parapsilosis ATCC 22019, C.
krusei ATCC 6258) and ketoconazole (Janssen-Cilag, Beerse) as a reference drug were involved. All fungal
strains were passaged on Sabouraud dextrose agar at 35C prior to being tested.
Minimal inhibitory concentration (MIC) was determined by the following method: Dimethyl sulfoxide
(DMSO) served as a diluent for all compounds tested. DMSO did not exceed the final concentration of 2 %.
As a test medium was used RPMI 1640 (Sevapharma, Prague), supplemented with L-glutamine and buffered
with 0.165 M morpholinepropanesulfonic acid (Serva) to pH 7.0 using 10 M NaOH. Each well of the
microdilution tray was filled with 200 ktl of the RPMI 1640 medium with a diluted compound tested and then
inoculated with 10 lal of suspension of a given fungal strain in sterile water. Fungal inoculum was prepared
3 to give a final size of 5 10 4- 0.2 CFU.mI. The trays were incubated at 35 C and the MICs were visually
read after 24 h and 48 h for all fungal strains tested except T. mentagrophytes (72 h and 120 h). The MIC was
defined as at least a 80 % inhibition ofthe growth of control.
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